Jyong Biotech Seeks US IPO On Thin Capitalization And Uphill Regulatory Battle

Jyong Biotech Ltd. ( MENS ) has filed proposed terms to raise $18.8 million from the sale of its common stock in an IPO, according to an amended F-1/A SEC registration statement .He also leads the investing group IPO Edge , which offers actionable information on growth stocks through first-look IPO filings, previews on upcoming IPOs, an IPO calendar for tracking what’s on the horizon, a database of U.S. IPOs, and a guide to IPO investing to walk you through the entire IPO lifecycle - from filing to listing ...